A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

NCT06538116 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Mevidalen
DRUG: Placebo

Sponsor

Eli Lilly and Company